WO2014157007A1 - Cosmetic preparation for skin - Google Patents

Cosmetic preparation for skin Download PDF

Info

Publication number
WO2014157007A1
WO2014157007A1 PCT/JP2014/057894 JP2014057894W WO2014157007A1 WO 2014157007 A1 WO2014157007 A1 WO 2014157007A1 JP 2014057894 W JP2014057894 W JP 2014057894W WO 2014157007 A1 WO2014157007 A1 WO 2014157007A1
Authority
WO
WIPO (PCT)
Prior art keywords
mass
extract
skin
component
application
Prior art date
Application number
PCT/JP2014/057894
Other languages
French (fr)
Japanese (ja)
Inventor
香織 谷口
尾林 裕子
Original Assignee
ライオン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライオン株式会社 filed Critical ライオン株式会社
Priority to JP2015508438A priority Critical patent/JP6271517B2/en
Publication of WO2014157007A1 publication Critical patent/WO2014157007A1/en
Priority to PH12015502172A priority patent/PH12015502172A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Definitions

  • the present invention relates to a skin cosmetic.
  • the present invention has no foaming and uneven color at the time of application, in addition to no stickiness at the time of application and after application, can prevent discoloration of the skin cosmetics, and changes within a range in which the skin color does not feel strange immediately after application.
  • An object of the present invention is to provide a skin cosmetic that has both the effect and the sustainability thereof and the long-term whitening effect.
  • the skin cosmetic of the present invention as a means for solving the above-mentioned problems is (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate, (C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide, (D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract.
  • the present invention it is possible to solve the above-described problems and achieve the above-mentioned object, there is no foaming and color unevenness at the time of application, and there is no stickiness at the time of application and after application. Discoloration can be prevented, and a skin cosmetic that combines the effect of changing the skin color within a range that does not feel uncomfortable immediately after application and the sustainability thereof, and the long-term whitening effect can be provided.
  • the skin cosmetic of the present invention is coated with (A) at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) at least one of stearic acid and potassium stearate, and (C) coated with titanium oxide. At least one of mica coated with titanium oxide containing mica and tin oxide, (D) water-swellable clay mineral, and (E) alpinia katsudai seed extract, (F) mixed extract, It contains other components as necessary.
  • the skin cosmetic of the present invention is emulsified using (A) at least one selected from cetyl alcohol, cetostearyl alcohol, and stearyl alcohol, and (B) at least one of stearic acid and potassium stearate.
  • these components act synergistically, There is no foaming or uneven color at the time, in addition to the non-stickiness at the time of application and after application, the skin cosmetics can be prevented from discoloring, and the effect of changing the skin color within the range that does not feel strange immediately after application
  • Cetyl alcohol, cetostearyl alcohol, stearyl alcohol As the component (A), at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol is used.
  • the cetyl alcohol is a higher saturated aliphatic alcohol having 16 carbon atoms and is represented as CH 3 (CH 2 ) 15 OH. Also called cetanol or palmityl alcohol.
  • the IUPAC system name is 1-hexadecanol.
  • the stearyl alcohol is a higher saturated aliphatic alcohol having 18 carbon atoms and is represented as CH 3 (CH 2 ) 17 OH.
  • the cetostearyl alcohol is a mixture of cetyl alcohol and stearyl alcohol, and is a mixture of a higher saturated aliphatic alcohol having 16 carbon atoms and a higher saturated aliphatic alcohol having 18 carbon atoms.
  • the content of at least one selected from cetyl alcohol, cetostearyl alcohol, and stearyl alcohol as the component (A) is non-sticky after application, no color unevenness, and the total amount of the skin cosmetics, and From the standpoint of sustaining the effect of changing the skin color within a range that does not give a sense of incongruity, the content is 0.5% by mass to 15% by mass, and preferably 2% by mass to 10% by mass. If the content is less than 0.5% by mass, stickiness after application may occur, or the effect of changing the skin color within a range that does not give an uncomfortable feeling may not be sufficiently maintained. May cause unevenness.
  • ⁇ (B) stearic acid, potassium stearate As the component (B), at least one of stearic acid and potassium stearate is used.
  • the stearic acid is a saturated higher fatty acid and is represented by the molecular formula C 17 H 35 COOH.
  • the IUPAC tissue name is octadecanoic acid.
  • the potassium stearate is the potassium salt of stearic acid.
  • the content of at least one of stearic acid and potassium stearate as the component (B) varies within a range in which foaming is suppressed, no stickiness after application, no stickiness after application, and skin color does not feel strange. From the standpoint of the durability of the effect and non-uniformity of the color, it is 0.5% by mass to 5% by mass and preferably 1.5% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic. If the content is less than 0.5% by mass, the stickiness is felt after coating, the sticking suppression effect over time after coating is not sufficiently obtained, or the effect of changing the skin color within a range in which the skin color does not feel strange does not last. In some cases, if it exceeds 5% by mass, foaming may occur during application or color unevenness may occur.
  • the mica coated with the titanium oxide is not particularly limited, and a commercially available product can be used.
  • Examples of the commercially available product include Timiron Super Gold (manufactured by Merck), Timiron Super Blue (manufactured by Merck), Timiron Super Red (Merck), Timiron Super Green (Merck), Timiron Super Sheen MP1001 (Merck), Timiron Super Sheen MP1005 (Merck), and so on. These may be used individually by 1 type and may use 2 or more types together.
  • the mica coated with the titanium oxide containing tin oxide is not particularly limited, and a commercially available product can be used.
  • a commercially available product examples include Ronafair Balance Gold (manufactured by Merck & Co., Inc.), Ronafair Balance Blue ( Merck), Ronafair Balance Red (Merck), and the like. These may be used individually by 1 type and may use 2 or more types together.
  • the content of at least one of the mica coated with titanium oxide of the component (C) and the mica coated with titanium oxide containing tin oxide is an effect of changing the skin color within a range in which the skin color does not feel strange immediately after application, and From the point of non-uniformity of color, it is 0.5% by mass to 5% by mass and preferably 1% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic. If the content is less than 0.5% by mass, the effect of changing the skin color immediately after application within a range in which the skin color does not feel uncomfortable may not be sufficient. If the content exceeds 5% by mass, the range in which the skin color does not feel uncomfortable immediately after application. The effect of changing the color may be insufficient or color unevenness may occur.
  • the water-swellable clay mineral of component (D) is not particularly limited and may be appropriately selected depending on the intended purpose.
  • montmorillonite and hectorite are preferable from the viewpoint of non-stickiness with time after coating, and montmorillonite having a swelling power of 50 mL / 2 g or more is particularly preferable.
  • the swelling power is determined according to the test method for the swelling power of bentonite according to the 15th revision Japanese Pharmacopoeia.
  • the test method for the swelling power of bentonite is specifically as follows. -Test method for the swelling power of bentonite (15th revision Japanese Pharmacopoeia)- Take 2.0 g of measurement sample (bentonite) and add to a 100 mL graduated cylinder containing 100 mL of water in 10 portions. However, after the previously added measurement sample is almost deposited, the next measurement sample is added. When this is left for 24 hours, the apparent volume of the container lump is above the 20 mL scale. That is, in the test method, the swelling power of the montmorillonite can be obtained by the same method as the test method except that the measurement sample is changed from bentonite to montmorillonite.
  • the water-swellable clay mineral (D) may be a natural product or a synthetic product. Commercial products can also be used. Examples of commercially available products of the component (D) include trade name Kunipia G (swelling power 50 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.), trade name Kunipia F (swelling power 45 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.).
  • Montmorillonite such as trade name Bengel FW (swelling force 35 mL / 2 g, manufactured by HOJUN Co., Ltd.); saponite such as Smecton SA (produced by Kunimine Kogyo Co., Ltd.); Examples include hectorite such as light (manufactured by Kunimine Kogyo Co., Ltd.); steven site such as trade name Ionite T (manufactured by Mizusawa Chemical Co., Ltd.) Among the montmorillonites, when comparing Kunipia G and Kunipia F, Kunipia G having a swelling power of 50 mL / 2 g or more is more preferable. These may be used alone or in combination of two or more.
  • the content of the water-swellable clay mineral of the component (D) is based on the non-stickiness with time after application and the sustainability of the effect of changing the skin color within a range in which the skin color does not feel strange,
  • the content is 0.1% by mass to 10% by mass, and more preferably 0.2% by mass to 5% by mass. If the content is less than 0.1% by mass, the effect of changing the skin color within a range that does not cause a sense of incongruity may not be sufficient, and if it exceeds 10% by mass, it will feel sticky over time after application. There is.
  • the (E) component Alpinia katsudai seed extract is a seed of Alpinia katsusumai Hayata extracted as it is or after pulverization with a solvent.
  • the solvent for obtaining the Alpinia katsudai seed extract is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include water, methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, and isobutanol.
  • Lower alcohol or hydrous lower alcohol propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3-pentane
  • Polyhydric alcohol or hydrous polyhydric alcohol such as diol, 1,4-pentanediol, 1,3,5-pentanetriol, glycerin, polyethylene glycol; acetone, ethyl acetate, diethyl ether, dimethyl ether, ethyl methyl ether, diol
  • organic solvents such as ethanol, acetonitrile, xylene, benzene, chloroform, carbon tetrachloride, phenol, toluene, etc .
  • acids eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc. adjusted to an appropriate degree
  • the above-mentioned Alpinia katsudai seed extract can be further subjected to a refining operation after solvent extraction.
  • the purification operation include decomposition by adding an acid (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (eg, sodium hydroxide, calcium hydroxide, ammonia, etc.), fermentation or metabolism by a microorganism.
  • an acid eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.
  • alkali eg, sodium hydroxide, calcium hydroxide, ammonia, etc.
  • the component (E) Commercially available products of the component (E) include, for example, the trade name Alpinia White (0.2% by mass as the pure extract of Alpinia katsudai seed extract, 69.9% by mass of 1,3-butylene glycol, and 29. 9% by mass, manufactured by Ichimaru Falcos Co., Ltd.).
  • the content of the component (E) Alpinia katsudai seed extract is not particularly limited and may be appropriately selected depending on the intended purpose. From the viewpoint of long-term whitening effect and no discoloration of the cream, the content (E ′) is preferably 0.0002% by mass to 0.02% by mass, more preferably 0.001% by mass to 0.01% by mass. .
  • a commercial item can be used, for example, brand name Plantage EX (0.5 mass% as a pure extract of a licorice root extract, an extract of Kawamomogi extract) 0.047% by mass as the pure content, 0.035% by mass as the pure extract of the Magwa root bark extract, 0.063% by mass as the pure extract of the jujube fruit extract, and 0.045% by mass as the pure extract of the Ogon extract 1,3-butylene glycol 79.405% by mass, and water 19.905% by mass, manufactured by Maruzen Pharmaceutical Co., Ltd.).
  • Plantage EX 0.5 mass% as a pure extract of a licorice root extract, an extract of Kawamomogi extract
  • the content of the component (F) is not particularly limited and may be appropriately selected depending on the intended purpose.
  • a pure extract (F ′) of a mixed extract consisting of an extract and an argon extract 0.00069% by mass to 0.069% by mass is preferable. 0.00345% by mass to 0.0345% by mass is more preferable.
  • the extraction solvent for obtaining each extract used in the present invention is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include water, methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, isobutanol and the like.
  • Lower alcohol or water-containing lower alcohol propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3- Polyhydric alcohols or hydrous polyhydric alcohols such as pentanediol, 1,4-pentanediol, 1,3,5-pentanetriol, glycerin, polyethylene glycol; acetone, ethyl acetate, diethyl ether, dimethyl ether, ethyl methyl ether, dioxane, A Various organic solvents such as tonitrile, xylene, benzene, chloroform, carbon tetrachloride, phenol, toluene, etc .; acids (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc.) adjusted to appropriate standards
  • Each extract used in the present invention can be further subjected to a refining operation after solvent extraction.
  • the purification operation include decomposition by adding an acid (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (eg, sodium hydroxide, calcium hydroxide, ammonia, etc.), fermentation or metabolism by a microorganism.
  • an acid eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.
  • alkali eg, sodium hydroxide, calcium hydroxide, ammonia, etc.
  • the skin cosmetic of the present invention can contain other components as necessary within a range not impairing the effects of the present invention.
  • the other components are not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include nonionic surfactants, silicone oils, ester oils and other oils, silicone powders, polymer compounds, moisturizing agents. Agents, inclusion compounds, vitamins, UV absorbers, UV scattering agents, amino acids, anti-inflammatory agents, cooling agents, antioxidants, colorants, fragrances, preservatives, solvents (eg, ethanol, etc.), fatty acids , Water (for example, purified water, ion-exchanged water, etc.), pH adjuster, and the like.
  • the content of the other components is not particularly limited and can be appropriately selected according to the purpose.
  • the purified water of the other components, the humectant of the other components, methyl paraoxybenzoate, and potassium hydroxide were weighed in a vessel of a vacuum emulsification kettle.
  • the polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state.
  • the component (A), the stearic acid of the component (B), the component (C), the propyl paraoxybenzoate, the titanium oxide, the nonporous spherical silicone powder, the oil component as the other components And the nonionic surfactant were dissolved by heating to 70 ° C.
  • a skin cosmetic can be produced by further cooling in minutes.
  • the pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
  • the purified water of the other components, the humectant of the other components, and methyl paraoxybenzoate and potassium hydroxide were weighed in a vacuum emulsification vessel vessel.
  • the polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state.
  • the oil and nonionic surfactant were dissolved by heating to 70 ° C.
  • a skin cosmetic can be produced by further cooling in minutes.
  • the pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
  • the dosage form of the skin cosmetic of the present invention is not particularly limited, and can be appropriately selected according to the purpose.
  • it can be selected as a liquid, cream, lotion, foam, gel, powder, Examples include emulsions and solids.
  • the skin cosmetics of the present invention can be used for, for example, day creams (day creams, day creams), makeup bases, powder foundations, cream foundations, liquid foundations, and the like.
  • Examples 1 to 47 and Comparative Examples 1 to 24 The skin cosmetics (day creams) of Examples 1 to 47 and Comparative Examples 1 to 24 having the compositions and contents shown in the following table are classified according to whether stearic acid or potassium stearate is used as the component (B). It was prepared as follows.
  • component (B) ⁇ When stearic acid is used as component (B)> Purified water, a humectant (1,3-butylene glycol, glycerin), methyl paraoxybenzoate, and potassium hydroxide were weighed in a vacuum emulsification vessel vessel according to the following table. A polymer compound (carboxyvinyl polymer) swollen with purified water was added thereto and heated to 70 ° C. under reduced pressure.
  • a humectant 1,3-butylene glycol, glycerin
  • methyl paraoxybenzoate methyl paraoxybenzoate
  • potassium hydroxide potassium hydroxide
  • component (A) or component (A ′), stearic acid or component (B ′) of component (B), component (C), propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone The powder, other oil (cyclopentasiloxane), and nonionic surfactant (sorbitan monostearate, glyceryl tri (caprylic / capric)) were heated to 70 ° C. and dissolved. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure.
  • (A) component, (B) component potassium stearate, (C) component, propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone powder, other oils (cyclopentasiloxane), And a nonionic surfactant (sorbitan monostearate, tri (caprylic acid / capric acid) glyceryl) were dissolved by heating to 70 ° C. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, add (D) component, (E) component, (F) component and the remaining common components as necessary, and further cool to 25 ° C. at 1 ° C./min. Cosmetics) were manufactured. The pH was measured with a pH meter (manufactured by TOA-DKK, HM-30G) at 25 ° C., and adjusted to pH 7.0 by adding citric acid.
  • X Five or less persons judged that it was favorable.
  • ⁇ E [ ⁇ (L value before application) ⁇ (L value after application) ⁇ 2 + ⁇ (a value before application) ⁇ (a value after application) ⁇ 2 + ⁇ (b value before application) ⁇ (B value after application) ⁇ 2 ] 1/2
  • the average value of ⁇ E is preferably 1.5 or more and less than 9.0, and preferably 3.0 or more and 6. Less than 0 is more preferable. If the average value of ⁇ E is less than 1.5, the change in color may not be known, and if it is 9.0 or more, the color may change too much and feel uncomfortable.
  • ⁇ Evaluation criteria Average value of ⁇ E is 0.0 or more and less than 1.5 ⁇ : Average value of ⁇ E is 1.5 or more and less than 3.0 ⁇ : Average value of ⁇ E is 3.0 or more and less than 6.0 ⁇ : Average of ⁇ E The value is 6.0 or more and less than 9.0 ⁇ : The average value of ⁇ E is 9.0 or more and less than 12.0 ⁇ : The average value of ⁇ E is 12.0 or more
  • ⁇ E ′ [ ⁇ (L value after 5 minutes after application) ⁇ (L value after application and normal life for 4 hours) ⁇ 2 + ⁇ (a value after 5 minutes after application) -(A value after applying and living a normal life for 4 hours) ⁇ 2 + ⁇ (b value after applying and 5 minutes after application)-(after applying and living a normal life for 4 hours) b value) ⁇ 2 ] 1/2
  • the average value of ⁇ E ′ is preferably 0.0 or more and less than 2.0. 0.0 or more and less than 1.0 is more preferable.
  • ⁇ Long-term whitening effect> L-value measurement using a melanin-containing three-dimensional skin model in which human normal skin cells are layered with a simple spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.) The measurement was performed with a human Lab value measurement using a spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.).
  • medium change every day serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, ⁇ -MSH, and ⁇ -FGF, trade names EPI-100LLM, MatTek
  • medium change every day serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, ⁇ -MSH, and ⁇ -FGF, trade names EPI-100LLM, MatTek
  • PBS phosphate buffered saline
  • a melanin-containing three-dimensional skin model (trade name MEL-312-A, manufactured by MatTek, melanin-containing three-dimensional skin, Asian donor) is incubated at 37 ° C. for 15 hours, and then 100 ⁇ g of PBS is applied to the skin in each cup.
  • Samples are replaced every two days, medium is replaced every day (serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, ⁇ -MSH, and ⁇ -FGF) (Trade name EPI-100LLM, manufactured by MatTek) and cultured at 37 ° C. for 15 days.
  • EPI-100LLM Trade name EPI-100LLM, manufactured by MatTek
  • the skin was fixed using 10% by mass formalin dissolved in PBS (phosphate buffered saline), the L value was measured, and the ⁇ L value was calculated based on the following formula.
  • ⁇ L (L value of cells coated with each sample ⁇ L value of cells coated with PBS used as a negative control) From the obtained average value of ⁇ L, long-term whitening effect was evaluated according to the following evaluation criteria.
  • the average value of ⁇ L is preferably 20 or more, and more preferably 30 or more. If the average value of ⁇ L is less than 20, the long-term whitening effect may not be sufficient.
  • ⁇ E ′′ [ ⁇ (L value before application) ⁇ (L value after one month) ⁇ 2 + ⁇ (a value before application) ⁇ (a value after one month) ⁇ 2 + ⁇ (b before application) Value) ⁇ (b value after one month) ⁇ 2 ] 1/2 From the obtained average value of ⁇ E ′′, long-term whitening effect was evaluated according to the following evaluation criteria.
  • the average value of ⁇ E ′′ is preferably 1.0 or more, and more preferably 2.0 or more.
  • the average value of ⁇ E ′′ is 2.0 or more ⁇ : The average value of ⁇ E ′′ is 1.0 or more and less than 2.0 ⁇ : The average value of ⁇ E ′′ is 0.5 or more and less than 1.0 ⁇ : The average of ⁇ E ′′ Value less than 0.5
  • the skin cosmetic of the present invention can be suitably used for, for example, day cream (daytime cream, daytime cream), makeup base, powder foundation, cream foundation, liquid foundation and the like.
  • Examples of the aspect of the present invention include the following. ⁇ 1> (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate, (C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide, (D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract, It is a skin cosmetic characterized by containing.
  • the skin cosmetic according to ⁇ 1> further comprising (F) a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and urgonum extract.
  • a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and urgonum extract.
  • the content of the component (E) alpinia katsudai seed extract is 0.001% by mass to 0.01% by mass in terms of pure extract, according to any one of ⁇ 1> to ⁇ 2> above It is a skin cosmetic.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

A cosmetic preparation for skin, which contains (A) 0.5-15% by mass of at least one alcohol selected from among cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) 0.5-5% by mass of stearic acid and/or potassium stearate, (C) 0.5-5% by mass of mica coated with titanium oxide and/or mica coated with titanium oxide containing tin oxide, (D) 0.1-10% by mass of a water-swellable clay mineral and (E) an alpinia katsumadai seed extract.

Description

皮膚化粧料Skin cosmetics
 本発明は、皮膚化粧料に関する。 The present invention relates to a skin cosmetic.
 日差しが強い夏季の日本、インドネシア等のアジアにおいて、デイクリームに必要とされる機能としては、塗布後にべたつきがなく、塗布後経時にもべたつかないことに加えて、塗布した直後から肌色を違和感のない範囲内で変化させる効果を有し、長期的に使用することで高い美白効果を有することなどが挙げられる。
 前記塗布した直後から肌色を違和感のない範囲内で変化させる効果を有する技術としては、例えば、酸化チタン被覆マイカを含む皮膚化粧料(特許文献1、2及び3参照)、酸化チタン被覆マイカの周りに更に酸化鉄(ベンガラ)を被覆したものを含み、肌色を変えることができる皮膚化粧料(特許文献4参照)、などが提案されている。
 一方、美白成分としては、例えば、アルブチン、コウジ酸、エラグ酸、などが知られている。
In Japan, Indonesia and other Asian countries where the sun is strong, the functions required for day cream are not sticky after application and not sticky over time after application. It has the effect of changing within a range that is not present, and has a high whitening effect when used for a long time.
Examples of the technology having an effect of changing the skin color within a range in which there is no sense of incongruity immediately after the application include, for example, skin cosmetics containing titanium oxide-coated mica (see Patent Documents 1, 2, and 3), Furthermore, skin cosmetics (see Patent Document 4) that can change the skin color, including those coated with iron oxide (Bengara), have been proposed.
On the other hand, as whitening components, for example, arbutin, kojic acid, ellagic acid and the like are known.
 しかし、前記塗布した直後から肌色を違和感のない範囲内で変化させる効果を有する粉体を用いた系に、前記美白成分を配合すると変色したり、分離してしまうという問題があり、塗布直後から肌色を違和感のない範囲内で変化させる効果と、長期的な美白効果との両方を十分満足できる皮膚化粧料は提供されていなかった。 However, there is a problem that when the whitening component is added to the system using the powder having the effect of changing the skin color within a range without uncomfortable feeling immediately after the application, there is a problem that the color changes or separates immediately after the application. There has not been provided a skin cosmetic that can sufficiently satisfy both the effect of changing the skin color within a range where there is no sense of incongruity and the long-term whitening effect.
 したがって、塗布時の泡立ち及び色むらがなく、塗布後のべたつきのなさ、塗布後経時のべたつきのなさに加え、皮膚化粧料の変色を防止でき、塗布した直後から肌色を違和感ない範囲内で変化させる効果及びその持続性と、長期的な美白効果とを兼ね備えた皮膚化粧料の提供が望まれている。 Therefore, there is no foaming or color unevenness at the time of application, in addition to the non-stickiness after application and the non-stickiness after application, it is possible to prevent discoloration of the skin cosmetics, and the skin color changes within the range that does not feel strange immediately after application. Therefore, it is desired to provide a skin cosmetic that has both a long-lasting whitening effect and a long-lasting whitening effect.
特開2005-232088号公報Japanese Patent Laid-Open No. 2005-232088 特開2005-200407号公報Japanese Patent Laid-Open No. 2005-200407 特開2009-242269号公報JP 2009-242269 A 特開2008-50271号公報JP 2008-50271 A
 本発明は、従来における前記諸問題を解決し、以下の目的を達成することを課題とする。即ち、本発明は、塗布時の泡立ち及び色むらがなく、塗布時及び塗布後経時のべたつきのなさに加え、皮膚化粧料の変色を防止でき、塗布した直後から肌色を違和感ない範囲内で変化させる効果及びその持続性と、長期的な美白効果とを兼ね備えた皮膚化粧料を提供することを目的とする。 This invention makes it a subject to solve the said various problems in the past and to achieve the following objectives. That is, the present invention has no foaming and uneven color at the time of application, in addition to no stickiness at the time of application and after application, can prevent discoloration of the skin cosmetics, and changes within a range in which the skin color does not feel strange immediately after application. An object of the present invention is to provide a skin cosmetic that has both the effect and the sustainability thereof and the long-term whitening effect.
 前記課題を解決するための手段としての本発明の皮膚化粧料は、(A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種を0.5質量%~15質量%、
(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかを0.5質量%~5質量%、
(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかを0.5質量%~5質量%、
(D)水膨潤性粘土鉱物を0.1質量%~10質量%、並びに
(E)アルピニアカツマダイ種子エキス、を含有する。
The skin cosmetic of the present invention as a means for solving the above-mentioned problems is (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol,
(B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate,
(C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide,
(D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract.
 本発明によると、従来における前記諸問題を解決し、前記目的を達成することができ、塗布時の泡立ち及び色むらがなく、塗布時及び塗布後経時のべたつきのなさに加え、皮膚化粧料の変色を防止でき、塗布した直後から肌色を違和感ない範囲内で変化させる効果及びその持続性と、長期的な美白効果とを兼ね備えた皮膚化粧料を提供することができる。 According to the present invention, it is possible to solve the above-described problems and achieve the above-mentioned object, there is no foaming and color unevenness at the time of application, and there is no stickiness at the time of application and after application. Discoloration can be prevented, and a skin cosmetic that combines the effect of changing the skin color within a range that does not feel uncomfortable immediately after application and the sustainability thereof, and the long-term whitening effect can be provided.
(皮膚化粧料)
 本発明の皮膚化粧料は、(A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種、(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれか、(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれか、(D)水膨潤性粘土鉱物、並びに(E)アルピニアカツマダイ種子エキス、を含有し、(F)混合エキス、更に必要に応じてその他の成分を含有してなる。
(Skin cosmetic)
The skin cosmetic of the present invention is coated with (A) at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) at least one of stearic acid and potassium stearate, and (C) coated with titanium oxide. At least one of mica coated with titanium oxide containing mica and tin oxide, (D) water-swellable clay mineral, and (E) alpinia katsudai seed extract, (F) mixed extract, It contains other components as necessary.
 本発明の皮膚化粧料は、前記(A)セチルアルコール、セトステアリルアルコール、及びステアリルアルコールから選択される少なくとも1種と、前記(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかとを用いて乳化した皮膚化粧料に、干渉光により肌の色味を変化させることのできる前記(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれか、前記(D)水膨潤性粘土鉱物、並びに前記(E)アルピニアカツマダイ種子エキス、好ましくは前記(F)カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキスを、それぞれ特定量で含有させることにより、これら成分が相乗的に作用して、塗布時の泡立ち及び色むらがなく、塗布時及び塗布後経時のべたつきのなさに加え、皮膚化粧料の変色を防止でき、塗布した直後から肌色を違和感ない範囲内で変化させる効果及びその持続性と、長期的な美白効果とを兼ね備えることができるという優れた技術的効果を奏する。 The skin cosmetic of the present invention is emulsified using (A) at least one selected from cetyl alcohol, cetostearyl alcohol, and stearyl alcohol, and (B) at least one of stearic acid and potassium stearate. To the skin cosmetic, at least one of the (C) mica coated with titanium oxide and the mica coated with titanium oxide containing tin oxide, which can change the color of the skin by interference light, (D ) Water-swellable clay minerals, and (E) Alpinia bonito seed extract, preferably (F) mixed extract consisting of licorice root extract, kawara mugwort extract, mugwort bark extract, jujube fruit extract, and ogon extract, By containing it in a specific amount, these components act synergistically, There is no foaming or uneven color at the time, in addition to the non-stickiness at the time of application and after application, the skin cosmetics can be prevented from discoloring, and the effect of changing the skin color within the range that does not feel strange immediately after application and its sustainability It has an excellent technical effect that it can have a long-term whitening effect.
<(A)セチルアルコール、セトステアリルアルコール、ステアリルアルコール>
 前記(A)成分としては、セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種が用いられる。
 前記セチルアルコールは、炭素数16の高級飽和脂肪族アルコールであり、CH(CH15OHと表される。セタノール、パルミチルアルコールとも呼ばれる。IUPAC系統名は1-ヘキサデカノールである。
 前記ステアリルアルコールは、炭素数18の高級飽和脂肪族アルコールであり、CH(CH17OHと表される。
 前記セトステアリルアルコールは、セチルアルコールとステアリルアルコールの混合物であり、炭素数16の高級飽和脂肪族アルコールと炭素数18の高級飽和脂肪族アルコールとの混合物である。
<(A) Cetyl alcohol, cetostearyl alcohol, stearyl alcohol>
As the component (A), at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol is used.
The cetyl alcohol is a higher saturated aliphatic alcohol having 16 carbon atoms and is represented as CH 3 (CH 2 ) 15 OH. Also called cetanol or palmityl alcohol. The IUPAC system name is 1-hexadecanol.
The stearyl alcohol is a higher saturated aliphatic alcohol having 18 carbon atoms and is represented as CH 3 (CH 2 ) 17 OH.
The cetostearyl alcohol is a mixture of cetyl alcohol and stearyl alcohol, and is a mixture of a higher saturated aliphatic alcohol having 16 carbon atoms and a higher saturated aliphatic alcohol having 18 carbon atoms.
 前記(A)成分のセチルアルコール、セトステアリルアルコール、及びステアリルアルコールから選択される少なくとも1種の含有量は、前記皮膚化粧料全量に対して、塗布後のべたつきのなさ、色むらのなさ、及び肌色を違和感ない範囲内で変化させる効果の持続性の点から、0.5質量%~15質量%であり、2質量%~10質量%が好ましい。前記含有量が、0.5質量%未満であると、塗布後のべたつきが生じたり、肌色を違和感ない範囲内で変化させる効果が十分に持続しないことがあり、15質量%を超えると、色むらを生じることがある。 The content of at least one selected from cetyl alcohol, cetostearyl alcohol, and stearyl alcohol as the component (A) is non-sticky after application, no color unevenness, and the total amount of the skin cosmetics, and From the standpoint of sustaining the effect of changing the skin color within a range that does not give a sense of incongruity, the content is 0.5% by mass to 15% by mass, and preferably 2% by mass to 10% by mass. If the content is less than 0.5% by mass, stickiness after application may occur, or the effect of changing the skin color within a range that does not give an uncomfortable feeling may not be sufficiently maintained. May cause unevenness.
<(B)ステアリン酸、ステアリン酸カリウム>
 前記(B)成分としては、ステアリン酸及びステアリン酸カリウムの少なくともいずれかが用いられる。
 前記ステアリン酸は、飽和高級脂肪酸であり、分子式C1735COOHで表される。IUPAC組織名はオクタデカン酸である。
 前記ステアリン酸カリウムは、前記ステアリン酸のカリウム塩である。
<(B) stearic acid, potassium stearate>
As the component (B), at least one of stearic acid and potassium stearate is used.
The stearic acid is a saturated higher fatty acid and is represented by the molecular formula C 17 H 35 COOH. The IUPAC tissue name is octadecanoic acid.
The potassium stearate is the potassium salt of stearic acid.
 前記(B)成分のステアリン酸及びステアリン酸カリウムの少なくともいずれかの含有量は、塗布時の泡立ち抑制、塗布後のべたつきのなさ、塗布後経時のべたつきのなさ、肌色を違和感ない範囲内で変化させる効果の持続性、及び色むらのなさの点から、前記皮膚化粧料全量に対して、0.5質量%~5質量%であり、1.5質量%~4.5質量%が好ましい。
 前記含有量が、0.5質量%未満であると、塗布後にべたつきを感じたり、塗布後経時のべたつき抑制効果が十分に得られなかったり、肌色を違和感ない範囲内で変化させる効果が持続しないことがあり、5質量%を超えると、塗布時に泡立ちを生じたり、色むらを生じることがある。
The content of at least one of stearic acid and potassium stearate as the component (B) varies within a range in which foaming is suppressed, no stickiness after application, no stickiness after application, and skin color does not feel strange. From the standpoint of the durability of the effect and non-uniformity of the color, it is 0.5% by mass to 5% by mass and preferably 1.5% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic.
If the content is less than 0.5% by mass, the stickiness is felt after coating, the sticking suppression effect over time after coating is not sufficiently obtained, or the effect of changing the skin color within a range in which the skin color does not feel strange does not last. In some cases, if it exceeds 5% by mass, foaming may occur during application or color unevenness may occur.
<(C)酸化チタンで被覆されたマイカ、酸化スズを含有する酸化チタンで被覆されたマイカ>
 前記(C)成分としては、酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかが用いられる。
<(C) Mica coated with titanium oxide, mica coated with titanium oxide containing tin oxide>
As the component (C), at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide is used.
 前記酸化チタンで被覆されたマイカとしては、特に制限はなく、市販品を用いることができ、前記市販品としては、例えば、Timiron Super Gold(メルク社製)、Timiron Super Blue(メルク社製)、Timiron Super Red(メルク社製)、Timiron Super Green(メルク社製)、Timiron Super Sheen MP1001(メルク社製)、Timiron Super Sheen MP1005(メルク社製)、などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The mica coated with the titanium oxide is not particularly limited, and a commercially available product can be used. Examples of the commercially available product include Timiron Super Gold (manufactured by Merck), Timiron Super Blue (manufactured by Merck), Timiron Super Red (Merck), Timiron Super Green (Merck), Timiron Super Sheen MP1001 (Merck), Timiron Super Sheen MP1005 (Merck), and so on. These may be used individually by 1 type and may use 2 or more types together.
 前記酸化スズを含有する酸化チタンで被覆されたマイカとしては、特に制限はなく、市販品を用いることができ、前記市販品としては、例えば、Ronaflair Balance Gold(メルク社製)、Ronaflair Balance Blue(メルク社製)、Ronaflair Balance Red(メルク社製)、などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The mica coated with the titanium oxide containing tin oxide is not particularly limited, and a commercially available product can be used. Examples of the commercially available product include Ronafair Balance Gold (manufactured by Merck & Co., Inc.), Ronafair Balance Blue ( Merck), Ronafair Balance Red (Merck), and the like. These may be used individually by 1 type and may use 2 or more types together.
 前記(C)成分の酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかの含有量は、塗布直後から肌色を違和感ない範囲内で変化させる効果、及び色むらのなさの点から、前記皮膚化粧料全量に対して、0.5質量%~5質量%であり、1質量%~4.5質量%が好ましい。
 前記含有量が、0.5質量%未満であると、塗布直後から肌色を違和感ない範囲内で変化させる効果が十分でないことがあり、5質量%を超えると、塗布直後から肌色を違和感ない範囲内で変化させる効果が不十分となったり、色むらが生じることがある。
The content of at least one of the mica coated with titanium oxide of the component (C) and the mica coated with titanium oxide containing tin oxide is an effect of changing the skin color within a range in which the skin color does not feel strange immediately after application, and From the point of non-uniformity of color, it is 0.5% by mass to 5% by mass and preferably 1% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic.
If the content is less than 0.5% by mass, the effect of changing the skin color immediately after application within a range in which the skin color does not feel uncomfortable may not be sufficient. If the content exceeds 5% by mass, the range in which the skin color does not feel uncomfortable immediately after application. The effect of changing the color may be insufficient or color unevenness may occur.
<(D)水膨潤性粘土鉱物>
 前記(D)成分の水膨潤性粘土鉱物としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ベントナイト、モンモリロナイト、バイデライト、ノントロナイト、サポナイト、ソーコナイト、ヘクトライト、スチブンサイト、などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、塗布後経時のべたつきのなさの点で、モンモリロナイト、ヘクトライトが好ましく、膨潤力が50mL/2g以上であるモンモリロナイトが特に好ましい。
<(D) Water-swellable clay mineral>
The water-swellable clay mineral of component (D) is not particularly limited and may be appropriately selected depending on the intended purpose. For example, bentonite, montmorillonite, beidellite, nontronite, saponite, sauconite, hectorite, stevensite , Etc. These may be used alone or in combination of two or more. Among these, montmorillonite and hectorite are preferable from the viewpoint of non-stickiness with time after coating, and montmorillonite having a swelling power of 50 mL / 2 g or more is particularly preferable.
 前記膨潤力は、第十五改正日本薬局方のベントナイトの膨潤力の試験方法に準じて求められる。ベントナイトの膨潤力の試験方法は、具体的には、以下のとおりである。
-ベントナイトの膨潤力の試験方法(第十五改正日本薬局方)-
 測定試料(ベントナイト)2.0gをとり、水100mLを入れた100mLメスシリンダーに10回に分けて加える。ただし、先に加えた前記測定試料がほとんど沈着した後、次の測定試料を加える。これを24時間放置するとき、容器の塊の見かけの容積は20mLの目盛り以上である。即ち、前記試験方法において、測定試料を、ベントナイトからモンモリロナイトに代える以外は、前記試験方法と同様の方法で、該モンモリロナイトの膨潤力を求めることができる。
The swelling power is determined according to the test method for the swelling power of bentonite according to the 15th revision Japanese Pharmacopoeia. The test method for the swelling power of bentonite is specifically as follows.
-Test method for the swelling power of bentonite (15th revision Japanese Pharmacopoeia)-
Take 2.0 g of measurement sample (bentonite) and add to a 100 mL graduated cylinder containing 100 mL of water in 10 portions. However, after the previously added measurement sample is almost deposited, the next measurement sample is added. When this is left for 24 hours, the apparent volume of the container lump is above the 20 mL scale. That is, in the test method, the swelling power of the montmorillonite can be obtained by the same method as the test method except that the measurement sample is changed from bentonite to montmorillonite.
 前記(D)成分の水膨潤性粘土鉱物は、天然物であってもよく、合成品であってもよい。また、市販品を用いることもできる。
 前記(D)成分の市販品としては、例えば、商品名クニピアG(膨潤力50mL/2g以上、クニミネ工業株式会社製)、商品名クニピアF(膨潤力45mL/2g以上、クニミネ工業株式会社製)、商品名ベンゲルFW(膨潤力35mL/2g、HOJUN株式会社製)等のモンモリロナイト;商品名スメクトンSA(クニミネ工業株式会社製)等のサポナイト;商品名HECTABRITE(株式会社ボルクレイ・ジャパン製)、合成ヘクトライト(クニミネ工業株式会社製)等のヘクトライト;商品名イオナイトT(水澤化学工業株式会社製)等のスチブンサイト、などが挙げられる。前記モンモリロナイトの中でも、クニピアGとクニピアFを比べると、膨潤力が50mL/2g以上であるクニピアGの方がより好ましい。これらは、1種単独で使用してもよく、2種以上を併用してもよい。
The water-swellable clay mineral (D) may be a natural product or a synthetic product. Commercial products can also be used.
Examples of commercially available products of the component (D) include trade name Kunipia G (swelling power 50 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.), trade name Kunipia F (swelling power 45 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.). Montmorillonite such as trade name Bengel FW (swelling force 35 mL / 2 g, manufactured by HOJUN Co., Ltd.); saponite such as Smecton SA (produced by Kunimine Kogyo Co., Ltd.); Examples include hectorite such as light (manufactured by Kunimine Kogyo Co., Ltd.); steven site such as trade name Ionite T (manufactured by Mizusawa Chemical Co., Ltd.) Among the montmorillonites, when comparing Kunipia G and Kunipia F, Kunipia G having a swelling power of 50 mL / 2 g or more is more preferable. These may be used alone or in combination of two or more.
 前記(D)成分の水膨潤性粘土鉱物の含有量は、塗布後経時のべたつきのなさ及び肌色を違和感ない範囲内で変化させる効果の持続性の点から、前記皮膚化粧料全量に対して、0.1質量%~10質量%であり、0.2質量%~5質量%がより好ましい。前記含有量が、0.1質量%未満であると、肌色を違和感ない範囲内で変化させる効果の持続性が十分でないことがあり、10質量%を超えると、塗布後経時でべたつきを感じることがある。 The content of the water-swellable clay mineral of the component (D) is based on the non-stickiness with time after application and the sustainability of the effect of changing the skin color within a range in which the skin color does not feel strange, The content is 0.1% by mass to 10% by mass, and more preferably 0.2% by mass to 5% by mass. If the content is less than 0.1% by mass, the effect of changing the skin color within a range that does not cause a sense of incongruity may not be sufficient, and if it exceeds 10% by mass, it will feel sticky over time after application. There is.
<(E)アルピニアカツマダイ種子エキス>
 前記(E)成分のアルピニアカツマダイ種子エキスは、ショウガ科アルピニアカツマダイ(Alpinia katsumadai Hayata)の種子を、そのままあるいは粉砕後、溶媒で抽出したものである。
<(E) Alpinia katsudai seed extract>
The (E) component Alpinia katsudai seed extract is a seed of Alpinia katsusumai Hayata extracted as it is or after pulverization with a solvent.
 前記アルピニアカツマダイ種子エキスを得るための溶媒としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、水、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール、ブタノール、イソブタノール等の低級アルコール又は含水低級アルコール;プロピレングリコール、1,3-ブチレングリコール、1,2-ブチレングリコール、1,4-ブチレングリコール、1,5-ペンタンジオール、1,2-ペンタンジオール、1,3-ペンタンジオール、1,4-ペンタンジオール、1,3,5-ペンタントリオール、グリセリン、ポリエチレングリコール等の多価アルコール又は含水多価アルコール;アセトン、酢酸エチル、ジエチルエーテル、ジメチルエーテル、エチルメチルエーテル、ジオキサン、アセトニトリル、キシレン、ベンゼン、クロロホルム、四塩化炭素、フェノール、トルエン等の各種有機溶媒;適宜規定度を調整した酸(例えば、塩酸、硫酸、硝酸、リン酸、ギ酸、酢酸等);アルカリ(例えば、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、アンモニア等)、などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、水、エタノール及び1,3-ブチレングリコールから選択される少なくとも1種が好ましい。ただし、用途により溶媒の含有が好ましくない場合においては、水のみを使用するか、あるいは抽出後に溶媒を除去しやすい、揮発性の高い溶媒を用いて抽出を行い、溶媒除去後水等に溶解させる方法も可能である。 The solvent for obtaining the Alpinia katsudai seed extract is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include water, methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, and isobutanol. Lower alcohol or hydrous lower alcohol; propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3-pentane Polyhydric alcohol or hydrous polyhydric alcohol such as diol, 1,4-pentanediol, 1,3,5-pentanetriol, glycerin, polyethylene glycol; acetone, ethyl acetate, diethyl ether, dimethyl ether, ethyl methyl ether, diol Various organic solvents such as ethanol, acetonitrile, xylene, benzene, chloroform, carbon tetrachloride, phenol, toluene, etc .; acids (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc.) adjusted to an appropriate degree; alkali ( For example, sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonia, etc.). These may be used alone or in combination of two or more. Among these, at least one selected from water, ethanol and 1,3-butylene glycol is preferable. However, if it is not preferable to use a solvent depending on the application, use only water or perform extraction using a highly volatile solvent that is easy to remove the solvent after extraction, and dissolve in water after removing the solvent. A method is also possible.
 前記アルピニアカツマダイ種子エキスは、溶媒抽出後、更に適宜精製操作を施すことも可能である。前記精製操作としては、例えば、酸(例えば、塩酸、硫酸、硝酸、リン酸、有機酸等)又はアルカリ(例えば、水酸化ナトリウム、水酸化カルシウム、アンモニア等)添加による分解、微生物による発酵又は代謝変換、イオン交換樹脂や活性炭、ケイ藻土等による成分吸着、種々の分離モード(例えば、イオン交換、親水性吸着、疎水性吸着、サイズ排除、配位子交換、アフィニティー等)を有するクロマトグラフィーを用いた分画、濾紙やメンブランフィルター、限外濾過膜等を用いた濾過、加圧又は減圧、加温又は冷却、乾燥、pH調整、脱臭、脱色、長時間の静置保管などが挙げられ、これらを任意に選択し組み合わせた処理を行うことが可能である。 The above-mentioned Alpinia katsudai seed extract can be further subjected to a refining operation after solvent extraction. Examples of the purification operation include decomposition by adding an acid (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (eg, sodium hydroxide, calcium hydroxide, ammonia, etc.), fermentation or metabolism by a microorganism. Conversion, component adsorption by ion exchange resin, activated carbon, diatomaceous earth, etc., chromatography with various separation modes (eg ion exchange, hydrophilic adsorption, hydrophobic adsorption, size exclusion, ligand exchange, affinity, etc.) Fractionation used, filtration using filter paper or membrane filter, ultrafiltration membrane, etc., pressurization or decompression, heating or cooling, drying, pH adjustment, deodorization, decolorization, long-term storage, etc. It is possible to perform processing by arbitrarily selecting and combining these.
 前記(E)成分の市販品としては、例えば、商品名アルピニアホワイト(アルピニアカツマダイ種子エキスのエキス純分として0.2質量%、1,3-ブチレングリコール69.9質量%、及び水29.9質量%、一丸ファルコス株式会社製)、などが挙げられる。 Commercially available products of the component (E) include, for example, the trade name Alpinia White (0.2% by mass as the pure extract of Alpinia katsudai seed extract, 69.9% by mass of 1,3-butylene glycol, and 29. 9% by mass, manufactured by Ichimaru Falcos Co., Ltd.).
 前記(E)成分のアルピニアカツマダイ種子エキスの含有量は、特に制限はなく、目的に応じて適宜選択することができるが、前記皮膚化粧料全量に対して、アルピニアカツマダイ種子エキスのエキス純分(E’)で、長期的な美白効果やクリームの変色のなさの点から、0.0002質量%~0.02質量%が好ましく、0.001質量%~0.01質量%がより好ましい。 The content of the component (E) Alpinia katsudai seed extract is not particularly limited and may be appropriately selected depending on the intended purpose. From the viewpoint of long-term whitening effect and no discoloration of the cream, the content (E ′) is preferably 0.0002% by mass to 0.02% by mass, more preferably 0.001% by mass to 0.01% by mass. .
<(F)カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキス>
 前記(F)成分の混合エキスとしては、特に制限はなく、市販品を用いることができ、例えば、商品名プランテージEX(カンゾウ根エキスのエキス純分として0.5質量%、カワラヨモギエキスのエキス純分として0.047質量%、マグワ根皮エキスのエキス純分として0.035質量%、ナツメ果実エキスのエキス純分として0.063質量%、オウゴンエキスのエキス純分として0.045質量%、1,3-ブチレングリコール79.405質量%、及び水19.905質量%、丸善製薬株式会社製)、などが挙げられる。
<(F) Mixed extract consisting of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and gourd extract>
There is no restriction | limiting in particular as a mixed extract of said (F) component, A commercial item can be used, for example, brand name Plantage EX (0.5 mass% as a pure extract of a licorice root extract, an extract of Kawamomogi extract) 0.047% by mass as the pure content, 0.035% by mass as the pure extract of the Magwa root bark extract, 0.063% by mass as the pure extract of the jujube fruit extract, and 0.045% by mass as the pure extract of the Ogon extract 1,3-butylene glycol 79.405% by mass, and water 19.905% by mass, manufactured by Maruzen Pharmaceutical Co., Ltd.).
 前記(F)成分の含有量は、特に制限はなく、目的に応じて適宜選択することができるが、前記皮膚化粧料全量に対して、カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキスのエキス純分(F’)で、長期的な美白効果やクリームの変色のなさが得られる点から、0.00069質量%~0.069質量%が好ましく、0.00345質量%~0.0345質量%がより好ましい。 The content of the component (F) is not particularly limited and may be appropriately selected depending on the intended purpose. However, with respect to the total amount of the skin cosmetic, licorice root extract, kawara mugwort extract, mugwort bark extract, jujube fruit From the point that a long-term whitening effect and no discoloration of the cream can be obtained with a pure extract (F ′) of a mixed extract consisting of an extract and an argon extract, 0.00069% by mass to 0.069% by mass is preferable. 0.00345% by mass to 0.0345% by mass is more preferable.
 本発明で用いる各エキスを得るための抽出溶媒としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、水、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール、ブタノール、イソブタノール等の低級アルコール又は含水低級アルコール;プロピレングリコール、1,3-ブチレングリコール、1,2-ブチレングリコール、1,4-ブチレングリコール、1,5-ペンタンジオール、1,2-ペンタンジオール、1,3-ペンタンジオール、1,4-ペンタンジオール、1,3,5-ペンタントリオール、グリセリン、ポリエチレングリコール等の多価アルコール又は含水多価アルコール;アセトン、酢酸エチル、ジエチルエーテル、ジメチルエーテル、エチルメチルエーテル、ジオキサン、アセトニトリル、キシレン、ベンゼン、クロロホルム、四塩化炭素、フェノール、トルエン等の各種有機溶媒;適宜規定度を調整した酸(例えば、塩酸、硫酸、硝酸、リン酸、ギ酸、酢酸等);アルカリ(例えば、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、アンモニア等)、などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、水、エタノール及び1,3-ブチレングリコールから選択される少なくとも1種が好ましい。ただし、用途により溶媒の含有が好ましくない場合においては、水のみを使用するか、あるいは抽出後に溶媒を除去しやすい、揮発性の高い溶媒を用いて抽出を行い、溶媒除去後水等に溶解させる方法も可能である。 The extraction solvent for obtaining each extract used in the present invention is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include water, methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, isobutanol and the like. Lower alcohol or water-containing lower alcohol; propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3- Polyhydric alcohols or hydrous polyhydric alcohols such as pentanediol, 1,4-pentanediol, 1,3,5-pentanetriol, glycerin, polyethylene glycol; acetone, ethyl acetate, diethyl ether, dimethyl ether, ethyl methyl ether, dioxane, A Various organic solvents such as tonitrile, xylene, benzene, chloroform, carbon tetrachloride, phenol, toluene, etc .; acids (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc.) adjusted to appropriate standards; alkalis (eg, Sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonia, etc.). These may be used alone or in combination of two or more. Among these, at least one selected from water, ethanol and 1,3-butylene glycol is preferable. However, if it is not preferable to use a solvent depending on the application, use only water or perform extraction using a highly volatile solvent that is easy to remove the solvent after extraction, and dissolve in water after removing the solvent. A method is also possible.
 本発明で用いる各エキスは、溶媒抽出後、更に適宜精製操作を施すことも可能である。前記精製操作としては、例えば、酸(例えば、塩酸、硫酸、硝酸、リン酸、有機酸等)又はアルカリ(例えば、水酸化ナトリウム、水酸化カルシウム、アンモニア等)添加による分解、微生物による発酵又は代謝変換、イオン交換樹脂や活性炭、ケイ藻土等による成分吸着、種々の分離モード(例えば、イオン交換、親水性吸着、疎水性吸着、サイズ排除、配位子交換、アフィニティー等)を有するクロマトグラフィーを用いた分画、濾紙やメンブランフィルター、限外濾過膜等を用いた濾過、加圧又は減圧、加温又は冷却、乾燥、pH調整、脱臭、脱色、長時間の静置保管などが挙げられ、これらを任意に選択し組み合わせた処理を行うことが可能である。 Each extract used in the present invention can be further subjected to a refining operation after solvent extraction. Examples of the purification operation include decomposition by adding an acid (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (eg, sodium hydroxide, calcium hydroxide, ammonia, etc.), fermentation or metabolism by a microorganism. Conversion, component adsorption by ion exchange resin, activated carbon, diatomaceous earth, etc., chromatography with various separation modes (eg ion exchange, hydrophilic adsorption, hydrophobic adsorption, size exclusion, ligand exchange, affinity, etc.) Fractionation used, filtration using filter paper or membrane filter, ultrafiltration membrane, etc., pressurization or decompression, heating or cooling, drying, pH adjustment, deodorization, decolorization, long-term storage, etc. It is possible to perform processing by arbitrarily selecting and combining these.
<その他の成分>
 本発明の皮膚化粧料は、本発明の効果を損なわない範囲で、必要に応じてその他の成分を含有することができる。
 前記その他の成分としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、非イオン性界面活性剤、シリコーン油、エステル油等の油分、シリコーン粉体、高分子化合物、保湿剤、包接化合物、ビタミン類、紫外線吸収剤、紫外線散乱剤、アミノ酸類、抗炎症剤、冷感付与剤、酸化防止剤、着色剤、香料、防腐剤、溶剤(例えば、エタノール等)、脂肪酸、水(例えば、精製水、イオン交換水等)、pH調整剤、などが挙げられる。前記その他の成分の含有量は、特に制限はなく、目的に応じて適宜選定することができる。
<Other ingredients>
The skin cosmetic of the present invention can contain other components as necessary within a range not impairing the effects of the present invention.
The other components are not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include nonionic surfactants, silicone oils, ester oils and other oils, silicone powders, polymer compounds, moisturizing agents. Agents, inclusion compounds, vitamins, UV absorbers, UV scattering agents, amino acids, anti-inflammatory agents, cooling agents, antioxidants, colorants, fragrances, preservatives, solvents (eg, ethanol, etc.), fatty acids , Water (for example, purified water, ion-exchanged water, etc.), pH adjuster, and the like. The content of the other components is not particularly limited and can be appropriately selected according to the purpose.
<製造方法>
 前記皮膚化粧料の製造方法としては、特に制限はなく、目的に応じて適宜選択することができるが、前記(B)成分としてステアリン酸を用いる場合と、ステアリン酸カリウムを用いる場合とで異なるので、以下に分けて説明する。
<Manufacturing method>
There is no restriction | limiting in particular as a manufacturing method of the said skin cosmetics, Although it can select suitably according to the objective, Since it differs by the case where a stearic acid is used as said (B) component and the case where potassium stearate is used, it is different. This will be described separately below.
-(B)成分としてステアリン酸を用いる場合-
 前記その他の成分の精製水、前記その他の成分の保湿剤、パラオキシ安息香酸メチル、及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた前記その他の成分の高分子化合物を添加し、減圧状態で、70℃に加温した。別のビーカーにて、前記(A)成分、前記(B)成分のステアリン酸、前記(C)成分、前記その他の成分としてのパラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、油分、及び非イオン性界面活性剤を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却する。冷却後、前記(D)成分、前記(E)成分、必要に応じて前記(F)成分、前記その他の成分としての香料、及び残りの前記その他の成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、皮膚化粧料を製造することができる。なお、pHは25℃の条件下、pHメーター(例えば、TOA-DKK株式会社製、HM-30G)で測定し、クエン酸の配合によってpH7.0に調整することができる。
-When stearic acid is used as component (B)-
The purified water of the other components, the humectant of the other components, methyl paraoxybenzoate, and potassium hydroxide were weighed in a vessel of a vacuum emulsification kettle. The polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state. In a separate beaker, the component (A), the stearic acid of the component (B), the component (C), the propyl paraoxybenzoate, the titanium oxide, the nonporous spherical silicone powder, the oil component as the other components And the nonionic surfactant were dissolved by heating to 70 ° C. After dissolution, while stirring the paddle, the dissolved oil and the like are added to the vessel and stirred, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, the component (D), the component (E), the component (F), the fragrance as the other component, and the remaining other components as necessary, are added, A skin cosmetic can be produced by further cooling in minutes. The pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
-(B)成分としてステアリン酸カリウムを用いる場合-
 前記その他の成分の精製水、前記その他の成分の保湿剤、及びパラオキシ安息香酸メチル及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた前記その他の成分の高分子化合物を添加し、減圧状態で、70℃に加温した。別のビーカーにて、前記(A)成分、前記(B)成分のステアリン酸カリウム、前記(C)成分、前記その他の成分としてのパラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、油分、及び非イオン性界面活性剤を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却する。冷却後、前記(D)成分、前記(E)成分、必要に応じて前記(F)成分、前記その他の成分としての香料、及び残りの前記その他の成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、皮膚化粧料を製造することができる。なお、pHは25℃の条件下、pHメーター(例えば、TOA-DKK株式会社製、HM-30G)で測定し、クエン酸の配合によってpH7.0に調整することができる。
-When potassium stearate is used as component (B)-
The purified water of the other components, the humectant of the other components, and methyl paraoxybenzoate and potassium hydroxide were weighed in a vacuum emulsification vessel vessel. The polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state. In a separate beaker, the component (A), the potassium stearate of the component (B), the component (C), the propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone powder as the other components, The oil and nonionic surfactant were dissolved by heating to 70 ° C. After dissolution, while stirring the paddle, the dissolved oil and the like are added to the vessel and stirred, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, the component (D), the component (E), the component (F), the fragrance as the other component, and the remaining other components as necessary, are added, A skin cosmetic can be produced by further cooling in minutes. The pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
-剤型-
 本発明の皮膚化粧料の剤型としては、特に制限されるものではなく、目的に応じて適宜選択することができ、例えば、液状、クリーム状、ローション状、泡状、ジェル状、パウダー状、乳液状、固形状、などが挙げられる。
-Dosage form-
The dosage form of the skin cosmetic of the present invention is not particularly limited, and can be appropriately selected according to the purpose. For example, it can be selected as a liquid, cream, lotion, foam, gel, powder, Examples include emulsions and solids.
-用途-
 本発明の皮膚化粧料は、例えば、デイクリーム(昼用クリーム、日中用クリーム)、化粧下地、パウダーファンデーション、クリームファンデーション、リキッドファンデーション、などに用いることができる。
-Applications-
The skin cosmetics of the present invention can be used for, for example, day creams (day creams, day creams), makeup bases, powder foundations, cream foundations, liquid foundations, and the like.
 以下、本発明の実施例を説明するが、本発明は、これらの実施例に何ら限定されるものではない。 Examples of the present invention will be described below, but the present invention is not limited to these examples.
(実施例1~47及び比較例1~24)
 下記表に示す組成及び含有量の実施例1~47及び比較例1~24の皮膚化粧料(デイクリーム)を、(B)成分としてステアリン酸を用いるか、ステアリン酸カリウムを用いるかにより分けて、以下のようにして調製した。
(Examples 1 to 47 and Comparative Examples 1 to 24)
The skin cosmetics (day creams) of Examples 1 to 47 and Comparative Examples 1 to 24 having the compositions and contents shown in the following table are classified according to whether stearic acid or potassium stearate is used as the component (B). It was prepared as follows.
<(B)成分としてステアリン酸を用いる場合>
 下記表に従って、精製水、保湿剤(1,3-ブチレングリコール、グリセリン)、パラオキシ安息香酸メチル、及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた高分子化合物(カルボキシビニルポリマー)を添加し、減圧状態で、70℃に加温した。別のビーカーにて、(A)成分又は(A’)成分、前記(B)成分のステアリン酸又は(B’)成分、(C)成分、パラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、その他の油分(シクロペンタシロキサン)、及び非イオン性界面活性剤(モノステアリン酸ソルビタン、トリ(カプリル酸/カプリン酸)グリセリル)を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却した。冷却後、(D)成分、(E)成分、必要に応じて(F)成分、及び残りの共通成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、デイクリーム(皮膚化粧料)を製造した。なお、pHは25℃の条件下、pHメーター(TOA-DKK株式会社製、HM-30G)で測定し、水酸化カリウムの配合によってpH7.0に調整した。
<When stearic acid is used as component (B)>
Purified water, a humectant (1,3-butylene glycol, glycerin), methyl paraoxybenzoate, and potassium hydroxide were weighed in a vacuum emulsification vessel vessel according to the following table. A polymer compound (carboxyvinyl polymer) swollen with purified water was added thereto and heated to 70 ° C. under reduced pressure. In another beaker, component (A) or component (A ′), stearic acid or component (B ′) of component (B), component (C), propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone The powder, other oil (cyclopentasiloxane), and nonionic surfactant (sorbitan monostearate, glyceryl tri (caprylic / capric)) were heated to 70 ° C. and dissolved. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, add (D) component, (E) component, (F) component and the remaining common components as necessary, and further cool to 25 ° C. at 1 ° C./min. Cosmetics) were manufactured. The pH was measured with a pH meter (manufactured by TOA-DKK, HM-30G) at 25 ° C., and adjusted to pH 7.0 by blending with potassium hydroxide.
<(B)成分としてステアリン酸カリウムを用いる場合>
 下記表に従って、精製水、保湿剤(1,3-ブチレングリコール、グリセリン)、パラオキシ安息香酸メチル、及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた高分子化合物(カルボキシビニルポリマー)を添加し、減圧状態で、70℃に加温した。別のビーカーにて、(A)成分、(B)成分のステアリン酸カリウム、(C)成分、パラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、その他の油分(シクロペンタシロキサン)、及び非イオン性界面活性剤(モノステアリン酸ソルビタン、トリ(カプリル酸/カプリン酸)グリセリル)を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却した。冷却後、(D)成分、(E)成分、必要に応じて(F)成分、及び残りの共通成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、デイクリーム(皮膚化粧料)を製造した。なお、pHは25℃の条件下、pHメーター(TOA-DKK株式会社製、HM-30G)で測定し、クエン酸の配合によってpH7.0に調整した。
<When using potassium stearate as component (B)>
Purified water, a humectant (1,3-butylene glycol, glycerin), methyl paraoxybenzoate, and potassium hydroxide were weighed in a vacuum emulsification vessel vessel according to the following table. A polymer compound (carboxyvinyl polymer) swollen with purified water was added thereto and heated to 70 ° C. under reduced pressure. In a separate beaker, (A) component, (B) component potassium stearate, (C) component, propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone powder, other oils (cyclopentasiloxane), And a nonionic surfactant (sorbitan monostearate, tri (caprylic acid / capric acid) glyceryl) were dissolved by heating to 70 ° C. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, add (D) component, (E) component, (F) component and the remaining common components as necessary, and further cool to 25 ° C. at 1 ° C./min. Cosmetics) were manufactured. The pH was measured with a pH meter (manufactured by TOA-DKK, HM-30G) at 25 ° C., and adjusted to pH 7.0 by adding citric acid.
 次に、作製した各皮膚化粧料(デイクリーム)について、「塗布時の泡立ちのなさ」、「塗布後のべたつきのなさ」、「塗布後経時のべたつきのなさ」、「肌色を違和感ない範囲内で変化させる効果(肌の色味変化)」及び「色むらのなさ」について、男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げた。各評価項目について、下記基準に基づき、官能評価を実施した。結果を表1~表15に示した。
 また、「クリームの変色のなさ」、「肌色を違和感ない範囲内で変化させる効果(肌の色味変化)の持続性」、及び「長期的な美白効果」について、以下のようにして評価した。結果を表1~表15に示した。
Next, for each skin cosmetic (day cream) produced, “no foaming at the time of application”, “no stickiness after application”, “no stickiness over time after application”, “within the range where the skin color does not feel strange "Effects of changing skin tone (changes in skin color)" and "Non-color irregularity" for 20 male and female panelists (10 males, 10 females, 20 to 40 years old) After washing with 1 g of the form “Plant Monogatari” (manufactured by Lion Corporation) and towel drying, 0.5 mL of each skin cosmetic was taken on the palm and spread on the face. For each evaluation item, sensory evaluation was performed based on the following criteria. The results are shown in Tables 1 to 15.
In addition, “no discoloration of the cream”, “sustainability of the effect of changing the skin color within a range that does not feel strange (skin color change)”, and “long-term whitening effect” were evaluated as follows. . The results are shown in Tables 1 to 15.
<塗布時の泡立ちのなさ(塗布時に評価)>
 男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)により、「塗布時の泡立ちのなさ」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
  ◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
  ○:10名以上13名以下が良好と判断した。
  △:6名以上9名以下が良好と判断した。
  ×:5名以下が良好と判断した。
<No foaming during application (evaluation during application)>
“No foaming at the time of application” was evaluated by 20 male and female panelists (10 males, 10 females, 20 to 40 years of age), and the following evaluation criteria were shown according to the number of respondents who answered that they were good.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
<皮膚化粧料(クリーム)の変色のなさ>
 各皮膚化粧料を60℃に1ヶ月保存し、対照として-5℃に1ヶ月保存した各皮膚化粧料と比較し、「クリームの変色のなさ」を女性専門パネラー1名により評価した。
 なお、「クリームの変色のなさ」とは、60℃で1ヶ月保存品について、-5℃で1ヶ月保存品と比較し、クリームの変色が認められないことを意味する。
〔評価基準〕
  ○:変色が認められなかった。
  ×:変色が認められた。
<No discoloration of skin cosmetics (cream)>
Each skin cosmetic was stored at 60 ° C. for 1 month, and compared with each skin cosmetic stored at −5 ° C. for 1 month as a control, “no discoloration of cream” was evaluated by one female panelist.
“No discoloration of the cream” means that the product stored at 60 ° C. for 1 month is not observed to be discolored compared to the product stored at −5 ° C. for 1 month.
〔Evaluation criteria〕
○: No discoloration was observed.
X: Discoloration was recognized.
<塗布後のべたつきのなさ>
 男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)について、「塗布後のべたつきのなさ」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
  ◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
  ○:10名以上13名以下が良好と判断した。
  △:6名以上9名以下が良好と判断した。
  ×:5名以下が良好と判断した。
<No stickiness after application>
Twenty male and female panelists (10 males, 10 females, 20 to 40 years of age) were evaluated for “non-stickiness after application” and indicated by the following evaluation criteria according to the number of respondents who answered that they were good.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
<塗布後経時のべたつきのなさ>
 男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)について、「塗布後経時のべたつきのなさ(塗布し、4時間後に評価)」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
  ◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
  ○:10名以上13名以下が良好と判断した。
  △:6名以上9名以下が良好と判断した。
  ×:5名以下が良好と判断した。
<No stickiness over time after application>
Number of respondents who evaluated 20 men and women specialized panelists (10 men, 10 women, 20 to 40 years of age) on “no stickiness over time after application (applied and evaluated after 4 hours)” Based on the following evaluation criteria.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
<色むらのなさ(塗布し、5分間後に評価)>
 男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)において、「色むらのなさ(塗布し、5分間後に評価)」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
  ◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
  ○:10名以上13名以下が良好と判断した。
  △:6名以上9名以下が良好と判断した。
  ×:5名以下が良好と判断した。
<No color irregularity (apply and evaluate after 5 minutes)>
20 male and female panelists (10 males, 10 females, 20 to 40 years old) evaluated “no color irregularity (applied and evaluated after 5 minutes)”, and evaluated according to the number of respondents who answered that they were good Shown by criteria.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
<肌色を違和感ない範囲内で変化させる効果(肌の色味変化)(塗布し、5分間後に評価)>
 塗布直後から肌色を違和感ない範囲内で変化させる効果については、簡易型分光色差計(NF333、日本電飾工業株式会社製)にてLab値の測定を行った。
 Lab値(L値が56~60、a値が8~10、b値が20~22)の男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後5分間後に、Lab値を測定した。そして、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げ、塗布し、5分間後に再度Lab値を測定し、下記計算式に基づきΔEを算出し、20名の専門パネラーのΔEの平均値を求めた。
 ΔE=[{(塗布前のL値)-(塗布後のL値)}+{(塗布前のa値)-(塗布後のa値)}+{(塗布前のb値)-(塗布後のb値)}1/2
 なお、肌色を違和感ない範囲内で変化させる効果としては、適度な色味の変化において嗜好性が高く、ΔEの平均値は、1.5以上9.0未満が好ましく、3.0以上6.0未満がより好ましい。前記ΔEの平均値が、1.5未満であると、色味の変化がわからないことがあり、9.0以上であると、色味が変化しすぎて違和感を感じることがある。
 求めたΔEの平均値から、以下の評価基準により、塗布直後から肌色を違和感ない範囲内で変化させる効果(肌の色味変化)について評価した。
〔評価基準〕
  △:ΔEの平均値が0.0以上1.5未満
  ○:ΔEの平均値が1.5以上3.0未満
  ◎:ΔEの平均値が3.0以上6.0未満
  ○:ΔEの平均値が6.0以上9.0未満
  △:ΔEの平均値が9.0以上12.0未満
  ×:ΔEの平均値が12.0以上
<Effect of changing skin color within a range that does not feel strange (skin color change) (applied and evaluated after 5 minutes)>
The Lab value was measured with a simple spectral color difference meter (NF333, manufactured by Nippon Denshoku Kogyo Co., Ltd.) for the effect of changing the skin color within a range in which the skin color does not feel strange immediately after application.
For 20 male and female panelists (10 males, 10 females, 20 to 40 years old) with Lab values (L value 56 to 60, a value 8 to 10, b value 20 to 22) The face was washed with 1 g of a face-washing form “Plant Monogatari” (manufactured by Lion Corporation), towel-dried, and after 5 minutes, the Lab value was measured. Then, take 0.5 mL of each skin cosmetic on the palm, spread and apply to the face, measure the Lab value again after 5 minutes, calculate ΔE based on the following formula, and calculate ΔE of 20 professional panelists The average value was obtained.
ΔE = [{(L value before application) − (L value after application)} 2 + {(a value before application) − (a value after application)} 2 + {(b value before application) − (B value after application)} 2 ] 1/2
In addition, as an effect of changing the skin color within a range that does not give a sense of incongruity, palatability is high in an appropriate color change, and the average value of ΔE is preferably 1.5 or more and less than 9.0, and preferably 3.0 or more and 6. Less than 0 is more preferable. If the average value of ΔE is less than 1.5, the change in color may not be known, and if it is 9.0 or more, the color may change too much and feel uncomfortable.
From the obtained average value of ΔE, the following evaluation criteria were used to evaluate the effect of changing the skin color immediately after application within a range where there is no sense of incongruity (skin color change).
〔Evaluation criteria〕
Δ: Average value of ΔE is 0.0 or more and less than 1.5 ○: Average value of ΔE is 1.5 or more and less than 3.0 ◎: Average value of ΔE is 3.0 or more and less than 6.0 ○: Average of ΔE The value is 6.0 or more and less than 9.0 Δ: The average value of ΔE is 9.0 or more and less than 12.0 ×: The average value of ΔE is 12.0 or more
<肌色を違和感ない範囲内で変化させる効果(肌の色味変化)の持続性>
 肌色を違和感ない範囲内で変化させる効果の持続性については、簡易型分光色差計(NF333、日本電色工業株式会社製)にてLab値の測定を行った。
 Lab値(L値が56~60、a値が8~10、b値が20~22)の男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げた。塗布し、5分間後、Lab値を測定し4時間通常通りの生活を送った。その後、再度Lab値を測定し、下記計算式に基づきΔE’を算出し、20名の専門パネラーのΔE’の平均値を求めた。
 ΔE’=[{(塗布し、5分間後のL値)-(塗布し、4時間通常通りの生活を送った後のL値)}+{(塗布し、5分間後のa値)-(塗布し、4時間通常通りの生活を送った後のa値)}+{(塗布し、5分間後のb値)-(塗布し、4時間通常通りの生活を送った後のb値)}1/2
 なお、肌色を違和感ない範囲内で変化させる効果の持続性については、色味の変化が少ないほうが嗜好性が高く、前記ΔE’の平均値は、0.0以上2.0未満が好ましく、0.0以上1.0未満がより好ましい。前記ΔE’の平均値が、2.0以上であると、色味が変化しすぎて肌色変化の持続性効果が十分ではないことがある。
 求めたΔE’の平均値から、以下の評価基準により、肌色を違和感ない範囲内で変化させる効果(肌の色味変化)の持続性について評価した。
〔評価基準〕
  ◎:ΔE’の平均値が0.0以上1.0未満
  ○:ΔE’の平均値が1.0以上2.0未満
  △:ΔE’の平均値が2.0以上3.0未満
  ×:ΔE’の平均値が3.0以上
<Sustainability of the effect of changing the skin color within a range that does not feel strange (skin color change)>
About the sustainability of the effect which changes skin color within the range which does not feel strange, the Lab value was measured with the simple spectral color difference meter (NF333, Nippon Denshoku Industries Co., Ltd.).
For 20 male and female panelists (10 males, 10 females, 20 to 40 years old) with Lab values (L value 56 to 60, a value 8 to 10, b value 20 to 22) The face was washed with 1 g of a face washing form “Plant Monogatari” (manufactured by Lion Corporation) and towel-dried, and then 0.5 mL of each skin cosmetic was taken on the palm and spread on the face. After application, 5 minutes later, the Lab value was measured and the normal life was spent for 4 hours. Thereafter, the Lab value was measured again, ΔE ′ was calculated based on the following formula, and the average value of ΔE ′ of 20 professional panelists was obtained.
ΔE ′ = [{(L value after 5 minutes after application) − (L value after application and normal life for 4 hours)} 2 + {(a value after 5 minutes after application) -(A value after applying and living a normal life for 4 hours)} 2 + {(b value after applying and 5 minutes after application)-(after applying and living a normal life for 4 hours) b value)} 2 ] 1/2
In addition, regarding the persistence of the effect of changing the skin color within a range in which the skin color does not feel uncomfortable, the smaller the change in color, the higher the preference, and the average value of ΔE ′ is preferably 0.0 or more and less than 2.0. 0.0 or more and less than 1.0 is more preferable. If the average value of ΔE ′ is 2.0 or more, the color may change too much and the sustaining effect of the skin color change may not be sufficient.
From the obtained average value of ΔE ′, the following evaluation criteria were used to evaluate the sustainability of the effect of changing the skin color within a range in which the skin color does not feel uncomfortable (skin color change).
〔Evaluation criteria〕
A: Average value of ΔE ′ is 0.0 or more and less than 1.0 ○: Average value of ΔE ′ is 1.0 or more and less than 2.0 Δ: Average value of ΔE ′ is 2.0 or more and less than 3.0 ×: The average value of ΔE 'is 3.0 or more
<長期的な美白効果>
 長期的な美白効果については、簡易型分光色差計(NF333、日本電色工業株式会社製)にてヒト正常皮膚細胞を重層培養したメラニン含有三次元皮膚モデルを用いたL値測定と、簡易型分光色差計(NF333、日本電色工業株式会社製)にてヒトでのLab値測定とで行った。
<<(1)ヒト正常皮膚細胞を重層培養したメラニン含有三次元皮膚モデルを用いた長期的な美白効果>>
 メラニン含有三次元皮膚モデル(商品名MEL-312-A、MatTek社製、メラニン含有3次元皮膚、Asian donor)を37℃で15時間インキュベートし、その後、各カップ内の皮膚に評価クリームを100μgずつ塗り、2日間ごとに培地を用いてクリームを洗い流し、新たに評価クリームを100μgずつ塗る工程を繰り返した。更に1日間ごとに培地交換(無血清培地、hEGF、ハイドロコーチゾン等増殖因子、ゲンタマイシンアンフォテリシンB、α-MSH、及びβ-FGFを含有している培地、商品名EPI-100LLM、MatTek社製)を行い、15日間37℃にて培養を行った。
 16日目に、PBS(Phosphate Buffered Saline)に溶解した10質量%ホルマリンを用いて皮膚を固定してL値を測定した。
 また、メラニン含有三次元皮膚モデル(商品名MEL-312-A、MatTek社製、メラニン含有3次元皮膚、Asian donor)を37℃で15時間インキュベートし、その後、各カップ内の皮膚にPBSを100μgずつ入れ、2日間ごとにサンプル交換、1日間ごとに培地交換(無血清培地、hEGF、ハイドロコーチゾン等増殖因子、ゲンタマイシンアンフォテリシンB、α-MSH、及びβ-FGFを含有している培地、商品名EPI-100LLM、MatTek社製)を行い、15日間37℃にて培養を行った。
 16日目に、PBS(Phosphate Buffered Saline)に溶解した10質量%ホルマリンを用いて皮膚を固定してL値を測定し、下記計算式に基づきΔL値を算出した。
 ΔL=(各サンプルを塗布した細胞のL値-ネガティブコントロールとして用いたPBSを塗布した細胞のL値)
 求めたΔLの平均値から、以下の評価基準により長期的な美白効果について評価した。
 なお、前記ΔLの平均値は、20以上が好ましく、30以上がより好ましい。前記ΔLの平均値が、20未満であると、長期的な美白効果が十分ではないことがある。
〔評価基準〕
  ◎:ΔLの平均値が30以上
  ○:ΔLの平均値が20以上30未満
  △:ΔLの平均値が10以上20未満
  ×:ΔLの平均値が10未満
<Long-term whitening effect>
For the long-term whitening effect, L-value measurement using a melanin-containing three-dimensional skin model in which human normal skin cells are layered with a simple spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.) The measurement was performed with a human Lab value measurement using a spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.).
<< (1) Long-term whitening effect using a melanin-containing three-dimensional skin model in which normal human skin cells are layered and cultured >>
A melanin-containing three-dimensional skin model (trade name MEL-312-A, manufactured by MatTek, melanin-containing three-dimensional skin, Asian donor) is incubated at 37 ° C. for 15 hours, and then 100 μg of evaluation cream is applied to the skin in each cup. The process of applying and washing out the cream every 2 days using the medium and applying 100 μg of the evaluation cream anew was repeated. Further, medium change every day (serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, α-MSH, and β-FGF, trade names EPI-100LLM, MatTek) And cultured at 37 ° C. for 15 days.
On the 16th day, the skin was fixed using 10% by mass formalin dissolved in PBS (phosphate buffered saline), and the L value was measured.
A melanin-containing three-dimensional skin model (trade name MEL-312-A, manufactured by MatTek, melanin-containing three-dimensional skin, Asian donor) is incubated at 37 ° C. for 15 hours, and then 100 μg of PBS is applied to the skin in each cup. Samples are replaced every two days, medium is replaced every day (serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, α-MSH, and β-FGF) (Trade name EPI-100LLM, manufactured by MatTek) and cultured at 37 ° C. for 15 days.
On the 16th day, the skin was fixed using 10% by mass formalin dissolved in PBS (phosphate buffered saline), the L value was measured, and the ΔL value was calculated based on the following formula.
ΔL = (L value of cells coated with each sample−L value of cells coated with PBS used as a negative control)
From the obtained average value of ΔL, long-term whitening effect was evaluated according to the following evaluation criteria.
The average value of ΔL is preferably 20 or more, and more preferably 30 or more. If the average value of ΔL is less than 20, the long-term whitening effect may not be sufficient.
〔Evaluation criteria〕
◎: The average value of ΔL is 30 or more ○: The average value of ΔL is 20 or more and less than 30 Δ: The average value of ΔL is 10 or more and less than 20 ×: The average value of ΔL is less than 10
<<(2)ヒトにおける長期的な美白効果>>
 Lab値(L値が56~60、a値が8~10、b値が20~22)の男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後5分間後に、Lab値を測定した。そして、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げる作業を1日1回ずつ1ヶ月間行った後、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後5分間後に、Lab値を測定し、下記計算式に基づきΔE”を算出し、20名の専門パネラーのΔE”の平均値を求めた。
 ΔE”=[{(塗布前のL値)-(1ヶ月後のL値)}+{(塗布前のa値)-(1ヶ月後のa値)}+{(塗布前のb値)-(1ヶ月後のb値)}1/2
 求めたΔE”の平均値から、以下の評価基準により、長期的な美白効果について評価した。なお、前記ΔE”の平均値は、1.0以上が好ましく、2.0以上がより好ましい。前記ΔE”の平均値が、1.0未満であると、長期的な美白効果が十分ではないことがある。
〔評価基準〕
  ◎:ΔE”の平均値が2.0以上
  ○:ΔE”の平均値が1.0以上2.0未満
  △:ΔE”の平均値が0.5以上1.0未満
  ×:ΔE”の平均値が0.5未満
<< (2) Long-term whitening effect in humans >>
For 20 male and female panelists (10 males, 10 females, 20 to 40 years old) with Lab values (L value 56 to 60, a value 8 to 10, b value 20 to 22) The face was washed with 1 g of a face-washing form “Plant Monogatari” (manufactured by Lion Corporation), towel-dried, and after 5 minutes, the Lab value was measured. Then, after taking 0.5 ml of each skin cosmetic on the palm and spreading it on the face once a day for 1 month, each face was cleaned with 1 g of the face washing form “Plant Story” (manufactured by Lion Corporation). After 5 minutes after washing and towel drying, the Lab value was measured, ΔE ″ was calculated based on the following formula, and the average value of ΔE ″ of 20 professional panelists was obtained.
ΔE ″ = [{(L value before application) − (L value after one month)} 2 + {(a value before application) − (a value after one month)} 2 + {(b before application) Value) − (b value after one month)} 2 ] 1/2
From the obtained average value of ΔE ″, long-term whitening effect was evaluated according to the following evaluation criteria. The average value of ΔE ″ is preferably 1.0 or more, and more preferably 2.0 or more. If the average value of ΔE ″ is less than 1.0, the long-term whitening effect may not be sufficient.
〔Evaluation criteria〕
◎: The average value of ΔE ″ is 2.0 or more ○: The average value of ΔE ″ is 1.0 or more and less than 2.0 △: The average value of ΔE ″ is 0.5 or more and less than 1.0 ×: The average of ΔE ″ Value less than 0.5
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
 実施例1~47及び比較例1~24で用いた各成分の具体的な内容は、下記の表16に示したとおりである。 Specific contents of each component used in Examples 1 to 47 and Comparative Examples 1 to 24 are as shown in Table 16 below.
Figure JPOXMLDOC01-appb-T000016
*9:アルピニアホワイト(アルピニアカツマダイ種子エキスのエキス純分として0.2質量%、1,3-ブチレングリコール69.9質量%、及び水29.9質量%、一丸ファルコス株式会社製)
*10:混合エキス(商品名プランテージEX、カンゾウ根エキスのエキス純分として0.5質量%、カワラヨモギエキスのエキス純分として0.047質量%、マグワ根皮エキスのエキス純分として0.035質量%、ナツメ果実エキスのエキス純分として0.063質量%、オウゴンエキスのエキス純分として0.045質量%、1,3-ブチレングリコール79.405質量%、及び水19.905質量%、丸善製薬株式会社製)
Figure JPOXMLDOC01-appb-T000016
* 9: Alpinia white (0.2% by mass, 19.9% by mass of 1,3-butylene glycol, and 29.9% by mass of water, manufactured by Ichimaru Falcos Co., Ltd.)
* 10: Mixed extract (trade name Plantage EX, 0.5% by mass as the extract of licorice root extract, 0.047% by mass as the extract of Kawaramugi extract, and 0.2% as the extract of mulberry root extract. 035% by weight, 0.063% by weight as a pure extract of jujube fruit extract, 0.045% by weight as a pure extract of ougon extract, 79.405% by weight of 1,3-butylene glycol, and 19.905% by weight of water Manufactured by Maruzen Pharmaceutical Co., Ltd.)
 本発明の皮膚化粧料は、例えば、デイクリーム(昼用クリーム、日中用クリーム)、化粧下地、パウダーファンデーション、クリームファンデーション、リキッドファンデーションなどに好適に用いることができる。 The skin cosmetic of the present invention can be suitably used for, for example, day cream (daytime cream, daytime cream), makeup base, powder foundation, cream foundation, liquid foundation and the like.
 本発明の態様としては、例えば、以下のものなどが挙げられる。
 <1> (A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種を0.5質量%~15質量%、
(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかを0.5質量%~5質量%、
(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかを0.5質量%~5質量%、
(D)水膨潤性粘土鉱物を0.1質量%~10質量%、並びに
(E)アルピニアカツマダイ種子エキス、
を含有することを特徴とする皮膚化粧料である。
 <2> 更に、(F)カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキスを含有する前記<1>に記載の皮膚化粧料である。
 <3> (E)成分のアルピニアカツマダイ種子エキスの含有量が、エキス純分で、0.001質量%~0.01質量%である前記<1>から<2>のいずれかに記載の皮膚化粧料である。
Examples of the aspect of the present invention include the following.
<1> (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol,
(B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate,
(C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide,
(D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract,
It is a skin cosmetic characterized by containing.
<2> The skin cosmetic according to <1>, further comprising (F) a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and urgonum extract.
<3> The content of the component (E) alpinia katsudai seed extract is 0.001% by mass to 0.01% by mass in terms of pure extract, according to any one of <1> to <2> above It is a skin cosmetic.

Claims (3)

  1.  (A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種を0.5質量%~15質量%、
    (B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかを0.5質量%~5質量%、
    (C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかを0.5質量%~5質量%、
    (D)水膨潤性粘土鉱物を0.1質量%~10質量%、並びに
    (E)アルピニアカツマダイ種子エキス、
    を含有することを特徴とする皮膚化粧料。
    (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol;
    (B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate,
    (C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide,
    (D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract,
    A skin cosmetic characterized by comprising
  2.  更に、(F)カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキスを含有する請求項1に記載の皮膚化粧料。 Furthermore, the skin cosmetic according to claim 1, further comprising (F) a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and ougong extract.
  3.  (E)成分のアルピニアカツマダイ種子エキスの含有量が、エキス純分で、0.001質量%~0.01質量%である請求項1から2のいずれかに記載の皮膚化粧料。 3. The skin cosmetic according to claim 1, wherein the content of the (E) component Alpinia katsudai seed extract is 0.001% by mass to 0.01% by mass in terms of pure extract.
PCT/JP2014/057894 2013-03-29 2014-03-20 Cosmetic preparation for skin WO2014157007A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2015508438A JP6271517B2 (en) 2013-03-29 2014-03-20 Skin cosmetics
PH12015502172A PH12015502172A1 (en) 2013-03-29 2015-09-16 Skin cosmetic

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013-073036 2013-03-29
JP2013073036 2013-03-29

Publications (1)

Publication Number Publication Date
WO2014157007A1 true WO2014157007A1 (en) 2014-10-02

Family

ID=51623984

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/057894 WO2014157007A1 (en) 2013-03-29 2014-03-20 Cosmetic preparation for skin

Country Status (4)

Country Link
JP (1) JP6271517B2 (en)
MY (1) MY177862A (en)
PH (1) PH12015502172A1 (en)
WO (1) WO2014157007A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106966913A (en) * 2017-04-06 2017-07-21 青岛科技大学 A kind of preparation method of improved methacrylic acid dialkylamino ethyl ester
JP2018172292A (en) * 2017-03-31 2018-11-08 株式会社コーセー Cosmetic or skin external preparation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001335499A (en) * 2000-05-29 2001-12-04 Ichimaru Pharcos Co Ltd Cosmetic composition
JP2002179521A (en) * 2000-12-13 2002-06-26 Ichimaru Pharcos Co Ltd Cosmetic composition containing extract of plant or animal
JP2006290749A (en) * 2005-04-06 2006-10-26 Ichimaru Pharcos Co Ltd Melanogenesis inhibitor
JP2007204379A (en) * 2006-01-31 2007-08-16 Ichimaru Pharcos Co Ltd FORMULATION AND METHOD FOR ACTIVATING mTOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4970720B2 (en) * 2003-12-15 2012-07-11 株式会社コーセー Oil-in-water makeup cosmetics
JP2005232088A (en) * 2004-02-19 2005-09-02 Kose Corp Oil-in-water type cosmetic
JP2008050271A (en) * 2006-08-22 2008-03-06 Shiseido Co Ltd Makeup cosmetic
JP2009242269A (en) * 2008-03-31 2009-10-22 Kose Corp Oil-in-water type emulsion cosmetic

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001335499A (en) * 2000-05-29 2001-12-04 Ichimaru Pharcos Co Ltd Cosmetic composition
JP2002179521A (en) * 2000-12-13 2002-06-26 Ichimaru Pharcos Co Ltd Cosmetic composition containing extract of plant or animal
JP2006290749A (en) * 2005-04-06 2006-10-26 Ichimaru Pharcos Co Ltd Melanogenesis inhibitor
JP2007204379A (en) * 2006-01-31 2007-08-16 Ichimaru Pharcos Co Ltd FORMULATION AND METHOD FOR ACTIVATING mTOR

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172292A (en) * 2017-03-31 2018-11-08 株式会社コーセー Cosmetic or skin external preparation
CN106966913A (en) * 2017-04-06 2017-07-21 青岛科技大学 A kind of preparation method of improved methacrylic acid dialkylamino ethyl ester

Also Published As

Publication number Publication date
PH12015502172A1 (en) 2016-01-25
JP6271517B2 (en) 2018-01-31
MY177862A (en) 2020-09-23
JPWO2014157007A1 (en) 2017-02-16

Similar Documents

Publication Publication Date Title
EP1713433B1 (en) Anti-wrinkle cosmetic
TW200520753A (en) Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer
JP4091824B2 (en) Skin preparation
KR101145060B1 (en) O/W cosmetic composition having improved cosmetics formulation stability
CH700328B1 (en) O / W emulsion for the care of the hand.
CN113576966B (en) Composition for cosmetics, preparation method and application thereof
JP2003267822A (en) Skin care preparation
JP4288306B2 (en) Cosmetics containing dimer dilinoleic acid diethylene glycol oligomer ester
JP4548831B2 (en) Hydrogenated retinoid or hydrogenated retinoid derivative and use thereof
JP6271517B2 (en) Skin cosmetics
KR102463133B1 (en) Cosmetic Composition Containing High-Content of Urea
JP2021098655A (en) Skin external composition
JP4035481B2 (en) Skin preparation
KR101462491B1 (en) Cosmetic Compositions for Moisturizing Lips
DE10036051A1 (en) Cosmetic or dermatological preparations for treating sun-tanning contain chitosan and lecithin to delay vaporization of volatile components
JP2001114635A (en) Cosmetic composition containing extract of muscovado
JP6834084B2 (en) Gentiana extract without gentiopicroside
JP5000964B2 (en) Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression
JP5856761B2 (en) External preparation for skin and method for producing the same
JP2009107984A (en) Oily composition containing dimer dilinoleic acid diethylene glycol oligomer ester
DE102020202565A1 (en) Improved preparation
JP3747192B2 (en) Topical skin preparation
JP5144048B2 (en) Radical scavenger, antioxidant skin external preparation, and radical scavenging method
JP2001199865A (en) Bleaching cosmetic
FR3109886A1 (en) Cosmetic composition comprising at least one calcareous red algae.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14775505

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015508438

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12015502172

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: IDP00201506984

Country of ref document: ID

122 Ep: pct application non-entry in european phase

Ref document number: 14775505

Country of ref document: EP

Kind code of ref document: A1